Operating income increased 10.8%
Operating income changed +10.8% from the comparable as-filed period.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Operating income changed +10.8% from the comparable as-filed period.
Total assets changed -23.8% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
Stock-based compensation changed -20.9% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
Working capital / assets changed -697 basis points from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
Free-cash-flow margin changed -377105 basis points from the comparable as-filed period.
Operating cash-flow margin changed -402116 basis points from the comparable as-filed period.
R&D / revenue changed +85783 basis points from the comparable as-filed period.
Current ratio changed -27.2% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
Current liabilities changed -2.8% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
Research & development changed -0.1% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Cash & equivalents changed from 0 to 0 USD in the comparable as-filed period. Relative percentage is de-emphasized because the comparison has a zero base.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.